| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 340 | 2021 |
| Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis F D’Addio, A Valderrama Vasquez, M Ben Nasr, E Franek, D Zhu, L Li, ... Diabetes 63 (9), 3041-3046, 2014 | 166 | 2014 |
| Role of podocyte B7-1 in diabetic nephropathy P Fiorina, A Vergani, R Bassi, MA Niewczas, MM Altintas, MG Pezzolesi, ... Journal of the American Society of Nephrology 25 (7), 1415-1429, 2014 | 146 | 2014 |
| PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes M Ben Nasr, S Tezza, F D’Addio, C Mameli, V Usuelli, A Maestroni, ... Science translational medicine 9 (416), eaam7543, 2017 | 129 | 2017 |
| Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site M Ben Nasr, A Vergani, J Avruch, L Liu, E Kefaloyianni, F D’Addio, ... Acta diabetologica 52, 917-927, 2015 | 114 | 2015 |
| Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens S Kleffel, A Vergani, S Tezza, M Ben Nasr, MA Niewczas, S Wong, ... Diabetes 64 (1), 158-171, 2015 | 111 | 2015 |
| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 104 | 2021 |
| Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy F D’Addio, S La Rosa, A Maestroni, P Jung, E Orsenigo, MB Nasr, ... Cell stem cell 17 (4), 486-498, 2015 | 99 | 2015 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological Research 182, 106320, 2022 | 95 | 2022 |
| The rise, fall, and resurgence of immunotherapy in type 1 diabetes MB Nasr, F D’Addio, V Usuelli, S Tezza, R Abdi, P Fiorina Pharmacological research 98, 31-38, 2015 | 80 | 2015 |
| PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response C Loretelli, A Abdelsalam, F D’Addio, MB Nasr, E Assi, V Usuelli, ... JCI insight 6 (24), 2021 | 55 | 2021 |
| Metabolomic profiling in individuals with a failing kidney allograft R Bassi, MA Niewczas, L Biancone, S Bussolino, S Merugumala, S Tezza, ... PloS one 12 (1), e0169077, 2017 | 49 | 2017 |
| Immunotherapy for type 1 diabetes D Frumento, M Ben Nasr, B El Essawy, F D’Addio, GV Zuccotti, P Fiorina Journal of endocrinological investigation 40, 803-814, 2017 | 41 | 2017 |
| Explaining the increased mortality in type 1 diabetes C Mameli, S Mazzantini, MB Nasr, P Fiorina, AE Scaramuzza, GV Zuccotti World journal of diabetes 6 (7), 889, 2015 | 37 | 2015 |
| Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome L Montefusco, F D’addio, C Loretelli, M Ben Nasr, M Garziano, A Rossi, ... Journal of Endocrinological Investigation, 1-9, 2021 | 36 | 2021 |
| P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes F D’Addio, A Vergani, L Potena, A Maestroni, V Usuelli, MB Nasr, R Bassi, ... The Journal of clinical investigation 128 (8), 3490-3503, 2018 | 36 | 2018 |
| Indirect and direct effects of SARS-CoV-2 on human pancreatic islets M Ben Nasr, F D’Addio, L Montefusco, V Usuelli, C Loretelli, A Rossi, ... Diabetes 71 (7), 1579-1590, 2022 | 35 | 2022 |
| Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy F D’Addio, A Trevisani, M Ben Nasr, R Bassi, B El Essawy, R Abdi, ... Acta diabetologica 51, 897-904, 2014 | 35 | 2014 |
| Cell therapy for type 1 diabetes C Loretelli, E Assi, AJ Seelam, M Ben Nasr, P Fiorina Expert opinion on biological therapy 20 (8), 887-897, 2020 | 33 | 2020 |
| Inhibition of the purinergic pathway prolongs mouse lung allograft survival K Liu, A Vergani, P Zhao, M Ben Nasr, X Wu, K Iken, D Jiang, X Su, ... American Journal of Respiratory Cell and Molecular Biology 51 (2), 300-310, 2014 | 32 | 2014 |
Paolo FiorinaUniversità degli Studi di Milano-Boston Children's Hospital-Harvard Medical School在 childrens.harvard.edu 的电子邮件经过验证
